Journal Club. Paul Rosenfeld and coworkers at the University of Toronto recently reported in the journal Viruses that Rocaglamide, a structurally novel natural product, inhibits HIV-1
Postdocs, we appreciate you! And to show our appreciation, Focus Biomolecules is offering 20% off our products. Click here to get the discount code.
The journal Cell is celebrating 50 years of metabolism research with a special Focus on Metabolism, illustrating its importance in so many processes and diseases.
Drug Approval News: The FDA has approved JNJ’s Rybrevant® (Amivantamab-vmjw plus Lazertinib) as a first line chemotherapy-free treatment for patients with EGFR-mutated advanced lung cancer. Lazertinib
August 1st is World RNA Day and Focus Biomolecules is celebrating! Check out our broad portfolio of small molecule research tools for studying RNA. Don’t see
Journal Club: An excellent review of the TRPV1 channel was recently published in Cell Calcium, covering its structure, activation, and modulation, as well as its role
Website Created by Advanta Advertising LLC.
